Tom Castles

Menopausal Hormone Therapy with Estrogen Alone Decreases Breast Cancer Incidence

December 14, 2019

Women who took estrogen alone as hormone therapy for their menopause experienced decreased rates of breast cancer and death from the disease even after they stopped taking the therapy, when compared to women who took estrogen with progestin.

Addition of Perjeta to Standard Care Improves Survival in HER2-Positive Early Breast Cancer

December 12, 2019

Researchers found that the addition of Perjeta to Herceptin plus chemotherapy reduced the relative risk for breast cancer recurrence or death in patients with operable HER2-positive early breast cancer, according to a six-year follow-up.

How Social Determinants of Health Affect Your Cancer Treatment

November 07, 2019

In this episode of the “CURE Talks Cancer” podcast, we spoke with Kassandra Alcaraz, PhD, MPH, about a new phenomenon that's gaining traction across the healthcare universe called the social determinants of health.

What Is (and What Isn't) Palliative Care?

October 31, 2019

In this episode of the “CURE Talks Cancer” podcast, we spoke with Donald Sullivan, MD, MA, MCR, associate professor of medicine at Oregon Health and Science University and the VA Portland healthcare system, about his research into palliative care and prolonged survival in patients with cancer.

Crowdfunding and the High Cost of Cancer

September 19, 2019

In this week’s episode of the “CURE Talks Cancer” podcast, we spoke with Dr. Benjamin Breyer about a phenomenon that’s raising big questions, big concerns and big money across the cancer landscape: crowdfunding.